Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis-Reference-Cited by-同舟云学术

Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis

Published:2021-03 Issue: Volume:223 Page:75-82
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Thulasi Praneetha^ORCID,Saeed Hajirah N.,Rapuano Christopher J.^ORCID,Hou Joshua H.,Appenheimer Alpheus B.^ORCID,Chodosh James,Kang Joann J.,Morrill Amber M.,Vyas Neil,Zegans Michael E.,Zuckerman Richard,Tu Elmer Y.

Funder

Research to Prevent Blindness

National Eye Institute

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

Ophthalmology

Reference40 articles.

1. Increasing incidence of Acanthamoeba keratitis in a large tertiary ophthalmology department from year 1994 to 2018;Nielsen;Acta Ophthalmol,2020

2. Microbiological profile of infectious keratitis in a Portuguese tertiary centre;Oliveira-Ferreira;J Ophthalmol,2019

3. Acanthamoeba in Southeast Asia - overview and challenges;Bunsuwansakul;Korean J Parasitol,2019

4. The rising incidence of Acanthamoeba keratitis: a 7-year nationwide survey and clinical assessment of risk factors and functional outcomes;Randag;PLoS One,2019

5. Scleral and intraocular amoebic dissemination in Acanthamoeba keratitis;Arnalich-Montiel;Cornea,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contact Lens-related Corneal Infections;Infectious Disease Clinics of North America;2024-09

2. Strathclyde minor groove binders (S-MGBs) with activity against Acanthamoeba castellanii;Journal of Antimicrobial Chemotherapy;2024-07-09

3. Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review;Cutaneous and Ocular Toxicology;2024-07-02

4. Infectious Keratitis in Patients Over 65: A Review on Treatment and Preserving Eyesight;Clinical Interventions in Aging;2024-07

5. Novel anti-Acanthamoeba effects elicited by a repurposed poly (ADP-ribose) polymerase inhibitor AZ9482;Frontiers in Cellular and Infection Microbiology;2024-05-28